EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting the WSB2–NOXA axis in cancer cells for enhanced sensitivity to BCL-2 family protein inhibitors

Dongyue Jiao iD, Kun Chang, Jiamin Jin, Yingji Chen, Mo Ren, Yucong Zhang, Kun Gao, Yaoting Xu, Lixin Wang, Chenji Wang iD

eLife · 2025

DOI: 10.7554/elife.98372 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, 2025. Verfasst von Dongyue Jiao und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Genetics and Development of Complex Phenotypes, Shanghai Stomatological Hospital and School of Stomatology, MOE Engineering R…. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-bcl-2, Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, State Key Development Programs of China, Natural Science Foundation of Shanghai Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anti-apoptotic B-cell lymphoma-2 (BCL-2) family proteins are frequently overexpressed in various cancers, playing a pivotal role in cancer initiation and progression, as well as intrinsic or acquired resistance to therapy. Although inhibitors targeting BCL-2, such as Venetoclax, have shown efficacy in hematological malignancies, their therapeutic potential in solid tumors remains limited. Identifying novel molecular targets to overcome resistance to these inhibitors is of significant clinical importance. Here, we provide evidence of a strong synthetic lethality between WSB2, a previously underexplored substrate-binding receptor of the Cullin 5–RBX2–Elongin B/C (CRL5) E3 ubiquitin ligase complex, and anti-apoptotic BCL-2 family proteins. Mechanistically, WSB assembles a CRL5 E3 ubiquitin ligase complex that facilitates the ubiquitination and subsequent proteasomal degradation of NOXA, a pro-apoptotic BCL-2 family protein. Loss of WSB2 leads to a substantial accumulation of NOXA in both cultured cell lines and knockout mouse tissues. While WSB2 deficiency alone does not significantly impact spontaneous apoptosis, it sensitizes cells to apoptosis when anti-apoptotic BCL-2 family proteins are either genetically depleted or pharmacologically inhibited. Moreover, WSB2 is overexpressed in several human cancer types. These findings identify WSB2 as a critical regulator of mitochondrial apoptosis and reveal the dysregulation of the WSB2–NOXA axis as a key factor contributing to apoptosis resistance in cancer cells. Targeting both WSB2 and anti-apoptotic BCL-2 family proteins holds promising therapeutic potential for overcoming resistance in human cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-bcl-2Antineoplastic AgentsNeoplasmsHumansAnimalsMiceCell Line, TumorApoptosisMice, KnockoutDrug Resistance, NeoplasmUbiquitination

Stichwörter der Autor:innen

VenetoclaxWSB2apoptosiscell biologydrug resistancehumanubiquitination

Substanzen

Proto-Oncogene Proteins c-bcl-2PMAIP1 protein, humanAntineoplastic Agents

Autor:innen und Institutionen

  • State Key Laboratory of Genetics and Development of Complex Phenotypes, Shanghai Stomatological Hospital and School of Stomatology, MOE Engineering Research Center of Gene Technology, Shanghai Engineering Research Cente…
  • Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Department of Urology, Inner Mongolia Urological Institute, Inner Mongolia Autonomous Region People's Hospital, Inner Mongolia, China.
  • Department of Vascular Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Department of Clinical Laboratory, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, China.

ORCID-Profile: Dongyue Jiao, Chenji Wang

Förderung

  • National Natural Science Foundation of China
  • State Key Development Programs of China
  • Natural Science Foundation of Shanghai Municipality
  • Science and Technology Research Program of Shanghai
  • Open Research Fund of the State Key Laboratory of Genetics and Development of Complex Phenotypes
  • Central Guidance on Local Science and Technology Development Foundation
  • China Postdoctoral Science Foundation

Zitieren

APA

Jiao, D., Chang, K., Jin, J., Chen, Y., Ren, M., Zhang, Y., Gao, K., Xu, Y., Wang, L., & Wang, C. (2025). Targeting the WSB2–NOXA axis in cancer cells for enhanced sensitivity to BCL-2 family protein inhibitors. eLife. https://doi.org/10.7554/elife.98372

Vancouver

Jiao D, Chang K, Jin J, Chen Y, Ren M, Zhang Y, et al. Targeting the WSB2–NOXA axis in cancer cells for enhanced sensitivity to BCL-2 family protein inhibitors. eLife. 2025. doi:10.7554/elife.98372

BibTeX
@article{Jiao2025,
  author = {Jiao, Dongyue and Chang, Kun and Jin, Jiamin and Chen, Yingji and Ren, Mo and Zhang, Yucong and Gao, Kun and Xu, Yaoting and Wang, Lixin and Wang, Chenji},
  title = {Targeting the WSB2–NOXA axis in cancer cells for enhanced sensitivity to BCL-2 family protein inhibitors},
  journal = {eLife},
  year = {2025},
  doi = {10.7554/elife.98372}
}
Kostenlos starten →